Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

New Jersey

Phase 1 colorectal cancer trials in New Jersey

23 Phase 1 colorectal cancer studies are recruiting participants at sites in 8 cities across New Jersey as of November 17, 2026, according to ClinicalTrials.gov.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every New Jersey city with a recruiting study

Hackensack (10), New Brunswick (8), East Brunswick (4), Morristown (3), Basking Ridge (1), Middletown (1), Montvale (1), Princeton (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in New Jersey

Basic details from each study's public record (the 12 most recently updated of 23). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Recruiting in
    New Brunswick
    Registry record
    NCT06253871 · updated
  2. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Basking Ridge · Hackensack · Middletown · and 2 more U.S. locations
    Registry record
    NCT07488676 · updated
  3. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Recruiting in
    New Brunswick
    Registry record
    NCT06004245 · updated
  4. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    East Brunswick · New Brunswick
    Registry record
    NCT06270706 · updated
  5. A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    IDEAYA Biosciences
    Recruiting in
    East Brunswick
    Registry record
    NCT07503808 · updated
  6. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Recruiting in
    Hackensack
    Registry record
    NCT07397338 · updated
  7. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Recruiting in
    Hackensack
    Registry record
    NCT07542704 · updated
  8. EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Eikon Therapeutics
    Recruiting in
    Morristown
    Registry record
    NCT07262619 · updated
  9. A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Inc
    Recruiting in
    Hackensack
    Registry record
    NCT07094204 · updated
  10. E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Christian Hinrichs
    Recruiting in
    New Brunswick
    Registry record
    NCT05639972 · updated
  11. KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kura Oncology, Inc.
    Recruiting in
    New Brunswick
    Registry record
    NCT06026410 · updated
  12. Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Princeton
    Registry record
    NCT07261631 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in New Jersey on ClinicalTrials.gov.

Ask about studies in New Jersey

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call